Decreasing the Effects of Aldosterone in Resistant Hypertension — A Success Story-Reference-Cited by-同舟云学术

Decreasing the Effects of Aldosterone in Resistant Hypertension — A Success Story

Published:2023-02-02 Issue:5 Volume:388 Page:461-463
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Azizi Michel¹

Affiliation:

1. From Université Paris Cité; Assistance Publique–Hôpitaux de Paris, Department of Hypertension and Département Médico–Universitaire Cardiologie Rein Transplantation Neurovasculaire, Hôpital Européen Georges Pompidou; and INSERM Centre d’Investigation Clinique 1418 — all in Paris.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMe2216143

Reference11 articles.

1. Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association

2. Prevalence of Apparent Treatment-Resistant Hypertension in the United States

3. Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

4. Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine

5. Aldosterone and Mineralocorticoid Receptors—Physiology and Pathophysiology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates on Mechanisms of Cytochrome P450 Catalysis of Complex Steroid Oxidations;International Journal of Molecular Sciences;2024-08-20

2. Use of Genomics to Develop Novel Therapeutics and Personalize Hypertension Therapy;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-04

3. Taming resistant hypertension: The promise of novel pharmacologic approaches and renal denervation;British Journal of Pharmacology;2023-10-21

4. Unilateral chemical ablation of the adrenal gland lowers blood pressure and alleviates target organ damage in spontaneously hypertensive rats;Hypertension Research;2023-10-03

5. Baxdrostat: An Aldosterone Synthase Inhibitor for the Treatment of Systemic Hypertension;Cardiology in Review;2023-08-07